CVI Holdings’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,197
Closed -$246K 80
2020
Q1
$246K Sell
5,197
-13,882
-73% -$654K 0.86% 20
2019
Q4
$801K Sell
19,079
-4,467
-19% -$193K 1.13% 15
2019
Q3
$1.11M Sell
23,546
-2,419
-9% -$107K 2.5% 12
2019
Q2
$1.18M Sell
25,965
-5,293
-17% -$241K 1.36% 15
2019
Q1
$1.66M Sell
31,258
-8,793
-22% -$430K 1.57% 14
2018
Q4
$1.36M Sell
40,051
-9,666
-19% -$426K 3.03% 8
2018
Q3
$2.83M Sell
49,717
-4,480
-8% -$284K 4.68% 6
2018
Q2
$4.17M Buy
+54,197
New +$4.36M 5.19% 6

Other funds holding NTBL

CVI Holdings's NTBL Position: Q2 2020 in Review

CVI Holdings sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q2 2020, closing a stake of 5,197 shares — an estimated $246K sold.

CVI Holdings first reported a position in NTBL in Q2 2018 and held it in 8 quarters. The position peaked at $4.17M in Q2 2018. 20 funds tracked by Wall St. Rank hold NTBL as of Q2 2020.

  • CVI Holdings reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q2 2020 after selling out during the quarter.
  • CVI Holdings sold 5,197 Notable Labs, Ltd. Ordinary Shares shares in Q2 2020, an estimated $246K.
  • CVI Holdings first reported a position in Notable Labs, Ltd. Ordinary Shares in Q2 2018 and held it in 8 quarters.
  • CVI Holdings's Notable Labs, Ltd. Ordinary Shares position peaked at $4.17M in Q2 2018.
  • 20 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q2 2020.

Based on CVI Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.